{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-005968","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.677219+00:00","generated_at":"2026-05-16T08:25:38.977331+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Corvus Pharmaceuticals prices $22.15/share public offering of ~9.1M shares for ~$188.3M net proceeds","bullets":["Upsized public offering of 7,900,677 shares at $22.15/share; underwriters fully exercised 30-day option for 1,185,101 additional shares.","Expected net proceeds of approximately $188.3 million after underwriting discounts and expenses.","Net proceeds to fund working capital and R&D for Phase 3 T cell lymphoma and Phase 2 atopic dermatitis, hidradenitis suppurativa, and asthma trials.","Offering expected to close on January 23, 2026; Jefferies and Goldman Sachs acted as lead underwriters."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-005968","json":"https://secwatch.observer/filing/0001104659-26-005968.json","markdown":"https://secwatch.observer/filing/0001104659-26-005968.md","text":"https://secwatch.observer/filing/0001104659-26-005968.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000110465926005968/0001104659-26-005968-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000110465926005968/tm263501d7_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:25:38.977331+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}